curium pharma

Private

Last Round

Private Equity

Dec 2, 2020

Last Round Size

$1.43B

Est. Valuation

$3.57B

Total Funding Raised

$1.43B

Company Overview

Developer and manufacturer of radiopharmaceutical products for diagnosing and treating cancer, heart, brain, and bone diseases.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare curium pharma with similar companies based on industry and business-model similarity.

Access detailed peer comparisons, similarity scores, and market data.

Historical fundraising activity

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about curium pharma's valuation, stock price, and market status.

Headquarters—

Year Founded2017

Last FundingDec 2, 2020

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.